Target Price | $72.50 |
Price | $66.14 |
Potential | 9.62% |
Number of Estimates | 24 |
24 Analysts have issued a price target Mondelez International 2026 . The average Mondelez International target price is $72.50. This is 9.62% higher than the current stock price. The highest price target is $81.00 22.47% , the lowest is $66.00 0.21% . | |
A rating was issued by 29 analysts: 19 Analysts recommend Mondelez International to buy, 10 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Mondelez International stock has an average upside potential 2026 of 9.62% . Most analysts recommend the Mondelez International stock at Purchase. |
21 Analysts have issued a sales forecast Mondelez International 2025 . The average Mondelez International sales estimate is $38.3b . This is 5.11% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $38.7b 6.23% , the lowest is $37.5b 2.92% .
This results in the following potential growth metrics:
2024 | $36.4b | 1.18% |
---|---|---|
2025 | $38.3b | 5.18% |
2026 | $39.9b | 4.20% |
2027 | $41.4b | 3.73% |
2028 | $43.2b | 4.21% |
2029 | $45.0b | 4.28% |
18 Analysts have issued an Mondelez International EBITDA forecast 2025. The average Mondelez International EBITDA estimate is $6.7b . This is 40.74% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.9b 45.38% , the lowest is $6.2b 29.44% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.8b | 16.88% |
---|---|---|
2025 | $6.7b | 2.29% |
2026 | $7.2b | 7.34% |
2027 | $7.7b | 6.56% |
2028 | $7.7b | 0.72% |
2029 | $8.6b | 12.03% |
2024 | 18.79% | 15.51% |
---|---|---|
2025 | 17.46% | 7.10% |
2026 | 17.99% | 3.04% |
2027 | 18.48% | 2.72% |
2028 | 17.86% | 3.35% |
2029 | 19.19% | 7.45% |
6 Mondelez International Analysts have issued a net profit forecast 2025. The average Mondelez International net profit estimate is $3.4b . This is 4.89% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.9b 7.87% , the lowest is $3.3b 9.39% .
This results in the following potential growth metrics and future Net Margins:
2024 | $4.6b | 7.02% |
---|---|---|
2025 | $3.4b | 25.72% |
2026 | $4.4b | 27.47% |
2027 | $4.8b | 8.96% |
2028 | $5.1b | 7.13% |
2029 | $5.5b | 7.19% |
2024 | 12.65% | 8.10% |
---|---|---|
2025 | 8.94% | 29.35% |
2026 | 10.93% | 22.26% |
2027 | 11.48% | 5.03% |
2028 | 11.80% | 2.79% |
2029 | 12.13% | 2.80% |
6 Analysts have issued a Mondelez International forecast for earnings per share. The average Mondelez International EPS is $2.65 . This is 3.64% lower than earnings per share in the financial year 2024. The highest EPS forecast is $3.00 9.09% , the lowest is $2.52 8.36% .
This results in the following potential growth metrics and future valuations:
2024 | $3.42 | 5.52% |
---|---|---|
2025 | $2.65 | 22.51% |
2026 | $3.37 | 27.17% |
2027 | $3.67 | 8.90% |
2028 | $3.94 | 7.36% |
2029 | $4.22 | 7.11% |
Current | 23.81 | 5.31% |
---|---|---|
2025 | 24.76 | 3.97% |
2026 | 19.42 | 21.57% |
2027 | 17.83 | 8.19% |
2028 | 16.64 | 6.67% |
2029 | 15.52 | 6.73% |
Based on analysts' sales estimates for 2025, the Mondelez International stock is valued at an EV/Sales of 2.68 and an P/S ratio of 2.21 .
This results in the following potential growth metrics and future valuations:
Current | 2.82 | 9.90% |
---|---|---|
2025 | 2.68 | 4.91% |
2026 | 2.57 | 4.04% |
2027 | 2.48 | 3.59% |
2028 | 2.38 | 4.04% |
2029 | 2.28 | 4.11% |
Current | 2.33 | 12.04% |
---|---|---|
2025 | 2.21 | 4.86% |
2026 | 2.12 | 4.03% |
2027 | 2.05 | 3.59% |
2028 | 1.96 | 4.04% |
2029 | 1.88 | 4.11% |
Mondelez International...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 01 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 30 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 28 2025 |
DA Davidson |
Buy
➜
Neutral
|
Downgrade | Apr 24 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 23 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 01 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 30 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 30 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 28 2025 |
Downgrade
DA Davidson:
Buy
➜
Neutral
|
Apr 24 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.